Waban, MA, United States of America

Laura Silvian

This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 7 EPO patents. Top assignees: Biogen Idec Ma Inc., Sunesis Pharmaceuticals, Inc., Biogen Ma Inc.. Active years: 2008-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Silvian. Retrieved from https://idiyas.com/inventor/laura-silvian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 66.7


 

Average Co-Inventor Count = 8.2

ph-index = 5

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2008-2020

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Inventor Laura Silvian: Pioneering Innovations in Waban, MA

Introduction: Laura Silvian is a visionary inventor based in Waban, Massachusetts, known for her groundbreaking contributions to various fields.

Latest Patents: Laura Silvian holds several patents in the areas of sustainable energy solutions, advanced medical devices, and innovative consumer electronics.

Career Highlights: With a career spanning over two decades, Laura Silvian has been at the forefront of technological advancements, leading research and development teams to create cutting-edge products that have revolutionized industries.

Collaborations: Throughout her career, Laura Silvian has collaborated with top research institutions, leading companies, and renowned universities to bring her ideas to life and turn them into successful inventions.

Conclusion: Laura Silvian's passion for innovation and her relentless drive to push the boundaries of what is possible make her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…